finance.yahoo.com
The health industry is plagued with many stumbling blocks these days, from new and controversial tech like AI to ever-increasing costs and an opaque health...
2 months ago
finance.yahoo.com
AstraZeneca reenters the weight loss drug race with a Chinese partner while Eli Lilly finally gets FDA approval for its drug, Zepbound.
2 months ago
finance.yahoo.com
Anthony Scaramucci, founder and managing partner of SkyBridge Capital, said during the Yahoo Finance Invest conference that he hopes to claw back the 30...
3 months ago
finance.yahoo.com
The potential of weight loss drugs is too appetizing for Wall Street to pass up. But they may not have the doomsday effect on food and health as some feared.
3 months ago
finance.yahoo.com
AstraZeneca is asking the FDA to let adults self-administer its nasal flu vaccine. It would be the first of its kind if the regulatory agency agrees.
3 months ago
finance.yahoo.com
AI in healthcare may one day play a dominant role, but for now it is still in a development phase.
3 months ago
finance.yahoo.com
AI in healthcare may one day play a dominant role, but for now it is still in a development phase.
3 months ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freefinance.yahoo.com
After stumbling several times, Amazon is now looking to others to help it build its healthcare efforts.
3 months ago
finance.yahoo.com
After stumbling several times, Amazon is now looking to others to help it build its health care efforts.
3 months ago
finance.yahoo.com
GLP-1s, the class of drugs taking the weight loss world by storm, may or may not be impacting overall food choices for customers. Retailers are waiting to...
4 months ago
finance.yahoo.com
Moderna CEO Stéphane Bancel says the company is working on a vaccine formula and packaging that will make it easier to use mNRA technology.
4 months ago
